The global progressive pulmonary fibrosis (PPF) treatment market is projected to be valued at USD 4,044.6 Million in 2025 and is expected to reach USD 8,182.4 Million by 2035, registering a CAGR of 7.3% during the forecast period, driven by the increasing prevalence of interstitial lung diseases (ILDs), which are the primary cause of PPF …